Inovio Pharmaceuticals vs Lisata Therapeutics
INO and LSTA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INO and LSTA compare
Inovio Pharmaceuticals is the larger company, worth 18 times as much as Lisata Therapeutics ($169M against $9.4M).
Lisata Therapeutics grew revenue faster over the last twelve months (−90.7% versus −100% for Inovio Pharmaceuticals).
Lisata Therapeutics scores higher on the StockData Score (6 against 4 for Inovio Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INO | LSTA |
|---|---|---|
| Size and price | ||
| Market cap | $169M | $9.4M |
| Share price | $1.63 | $1.04 |
| Change, 1 year | −20.5% | −50.9% |
| Change, 5 years | −98.1% | −92.9% |
| Beta (5Y) | −0.26 | −1.59 |
| Employees | 27 | 21 |
| StockData Score | ||
| Total score | 4 | 6 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 93.7× |
| P/B | 38.6× | 1.1× (better) |
| FCF yield | −47.9% (better) | −131% |
| Growth | ||
| Revenue growth (TTM) | −100% | −90.7% (better) |
| Revenue growth, 5Y average | −61.2% | – |
| Profitability | ||
| Operating margin | – | −16427% |
| Net margin | – | −14621% |
| FCF margin | – | −12323% |
| Return on equity | −410% | −99.9% (better) |
| Return on invested capital | – | −1645% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.00 | 3.69 (better) |
| Altman Z-score | −55.23 (better) | −74.81 |
| Piotroski F-score | 1 | 1 |
| Dividends and buybacks | ||
| Buyback yield | −22.6% | −6.3% (better) |
| Shareholder yield | −22.6% | −6.3% (better) |
| Ownership | ||
| Held by institutions | 31.7% | 12.1% |
| Held by insiders | 0.38% | 11.6% |
| Short interest, % of float | 21.5% | 0.43% |
Go deeper
- INO stock overview
- INO income statement
- INO valuation and score
- LSTA stock overview
- LSTA income statement
- LSTA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.